Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
NCT07573163
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Mild Autonomous Cortisol Secretion (MACS)
Adrenalectomy; Status
Interventions
DRUG:
Tirzepatide
OTHER:
Standard medical treatment
Sponsor
Alaa Sada